|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 277/68 | (2006.01) |
| A61K 31/428 | (2006.01) | ||
| A61P 21/00 | (2006.01) |
| (11) | Number of the document | 2890687 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13812075.3 |
| Date of filing the European patent application | 2013-08-29 | |
| (97) | Date of publication of the European application | 2015-07-08 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-28 |
| (46) | Date of publication of the claims translation | 2017-09-11 |
| (86) | Number | PCT/IB2013/058109 |
| Date | 2013-08-29 |
| (87) | Number | WO 2014/033654 |
| Date | 2014-03-06 |
| (30) | Number | Date | Country code |
| 2392012 | 2012-08-30 | IQ |
| (72) |
GRANDEURY, Arnaud, CH
TUFILLI, Nicola, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Benzotiazolono junginio druskos, kaip beta-2-adrenoceptoriaus agonistai |
| SALTS OF BENZOTHIAZOLONE COMPOUND AS BETA-2-ADRENOCEPTOR AGONIST |
| Payment date | Validity (years) | Amount | |
| 2018-07-26 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-08-29 |